Surgical or medical interventions for female genital mutilation.
Deinfibulation can prevent or treat gynecological and obstetric complications in women living with type III female genital mutilation (FGM), and subsequently improve childbirth outcomes. Recently published WHO guidelines recommend use of deinfibulation in both circumstances. However, to really impact practice, evidence-based guidance needs to be matched with evidence-based implementation strategies. This qualitative evidence synthesis provides information on the factors that facilitate or act as barriers to use of deinfibulation, and the context and conditions that are necessary for implementing the procedure, including healthcare providers' knowledge and experience, the service delivery environment, as well as broader health system contexts. This information is of great value for policy makers and others considering this as an option for better clinical care of women living with FGM.
Centre for Maternal and Newborn Health, Liverpool School of Tropical Medicine, Liverpool, UK.
Helen
H
Smith
Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Karin
K
Stein
D002921:Cicatrix / Q000601:surgery; D019093:Circumcision, Female / Q000009:adverse effects* / Q000145:classification; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006282:Health Personnel / Q000193:education*; D006801:Humans; D007744:Obstetric Labor Complications / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy*; D036801:Parturition; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D012086:Reoperation / Q000592:standards*; D014844:Vulva / Q000601:surgery; D014944:World Health Organization
Deinfibulation; Female genital mutilation; Health complications; Qualitative synthesis; Surgical intervention